Stock listing
SVA Stock Price, News, Filings & Events — Sinovac Biotech, Ltd.
Selected listing: SVA · NASDAQ · USD · US
This page tracks Sinovac Biotech, Ltd.'s SVA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SVA:NASDAQ. SVA:NASDAQ is the stock-level entry point for investors researching Sinovac Biotech, Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sinovac Biotech, Ltd. is a public company traded under the ticker SVA in the American market. The company has a market capitalization of approximately $464.9 million. Sinovac focuses on the development and commercialization of vaccines and biopharmaceutical products.

- Ticker
- SVA:NASDAQ
- Asset type
- Stock
- Market cap
- $464.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Sinovac Biotech, Ltd. SVA:NASDAQ stock context
This page tracks Sinovac Biotech, Ltd.'s SVA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SVA:NASDAQ. SVA:NASDAQ is the stock-level entry point for investors researching Sinovac Biotech, Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sinovac Biotech, Ltd. is a public company traded under the ticker SVA in the American market. The company has a market capitalization of approximately $464.9 million. Sinovac focuses on the development and commercialization of vaccines and biopharmaceutical products.
Research Sinovac Biotech, Ltd.
Sinovac Biotech, Ltd. investor report
Review AI stock analysis and investor report context for SVA:NASDAQ.
Sinovac Biotech, Ltd. company profile
View the public company page for Sinovac Biotech, Ltd. on 6ix.
Sinovac Biotech, Ltd. news
Read company news and market updates connected to Sinovac Biotech, Ltd..
Sinovac Biotech, Ltd. investor events
Find investor webinars, events, and replay context for Sinovac Biotech, Ltd..